Biogen (NASDAQ: BIIB) reported Q1 EPS of $3.62, $0.76 worse than the analyst estimate of $4.38. Revenue for the quarter came in at $2.53 billion versus the consensus estimate of $2.5 billion.

• Announces CEO Transition
• Reaffirms FY Guidance

For earnings history and earnings-related data on Biogen (BIIB) click here.

Corporate News Earnings Hot Corp. News Hot Earnings Hot Mgmt Changes Management Changes